ZNX-15160-28851
3 vaccinations
5 coded responses
38 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 780 / TX
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Registered in v-safe
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
- 2021-03-22
-
2021-03-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-04-02
-
2021-04-11
Dose 2 — Pfizer-BioNTech
- 2021-04-11
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to workAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Nausea · Be unable to workAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-20
- 2021-04-25
- 2021-05-02
- 2021-05-09
- 2021-05-16
- 2021-05-23
- 2021-07-11
-
2021-10-10
Survey response — 6 months, dose 2MedDRA: Respiratory disorder — Feeling: FairFree text: Still have some issues with breathing but nothing that I can't handle.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-23
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-23
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolFree text: Lack of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-10-25
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · None · Be unable to work or attend schoolAdult check-in
- 2021-10-26
- 2021-10-27
- 2021-10-28
- 2021-10-29
-
2021-10-30
Health check-in — day 7, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-06
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-04
-
2022-01-22
Survey response — 3 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: CovidMedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-01-24
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-04-26
Survey response — 6 months, dose 3MedDRA: Gastrointestinal disorder — Feeling: Fair · Be unable to work or attend schoolFree text: Stomach/GI issuesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: ColdMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-10-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-10-23 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-22 | Successful 2022-01-24 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
| 2022-10-23 | Successful 2022-10-25 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — 6 months, dose 2
Symptoms: Still have some issues with breathing but nothing that I can't handle.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Lack of appetite
Release 11 — 3 months, dose 3
Symptoms: Covid
Release 11 — 6 months, dose 3
Symptoms: Stomach/GI issues
Release 12 — 12 months, dose 3
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gastrointestinal disorder | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release